GENMAB A/S - Ordinary Shares, nominal value DKK 1 per share (GMAB)

CUSIP: 372303206

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
-200,505
SEC-reported price per share
$35.68
Number of holders
54
Value change
-$6,925,704
Number of buys
26
Number of sells
15
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
62,174,746

Security key

372303206

Report period

Q3 2026

Institutions

54

Top holders

10

Ownership snapshot

Top reported holders of GMAB - GENMAB A/S - Ordinary Shares, nominal value DKK 1 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Darwin Global Management,...
Disclosed value leader
Paradigm Biocapital Advis...
Comparable rows
3/15
Latest evidence
28 Sep 2026
13D/G 13F Lead comparable stake: 5.9% 12 rows are not safely comparable across share classes. 13D/G row: Darwin Global Management, Ltd. Showing 1-6 of 15 holder rows.

Quick read

Darwin Global Management, Ltd. leads the comparable SEC ownership view at 5.9%.

3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Darwin Global Management, Ltd.'s linked filing trail.
Comparable ownership Top 3
Darwin Global Management, Ltd. 5.9%
BlackRock, Inc. 5.6%
ORBIS INVESTMENT MANAGEMENT LTD 5.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Darwin Global Management, Ltd.
13D/G
5.9%
Reported 13D/G · 28 Sep 2026
$122,998,434
3,668,310 shares
$0 28 Sep 2026
BlackRock, Inc.
13F 13D/G
Company
5.6%
Reported 13D/G · 31 Mar 2025
$128,319,300
4,671,252 shares
— 30 Jun 2026
ORBIS INVESTMENT MANAGEMENT LTD
13D/G
5.3%
Reported 13D/G · 30 Jun 2026
—
3,320,695 shares
$0 30 Jun 2026
Paradigm Biocapital Advisors LP
13F
Company
13F
—
denominator unverified
$360,767,109
13,133,131 shares
— 30 Jun 2026
Orbis Allan Gray Ltd
13F
Company
13F
—
denominator unverified
$312,283,383
11,368,161 shares
— 30 Jun 2026
ALLIANCEBERNSTEIN L.P.
13F
Company
13F
—
denominator unverified
$231,942,050
8,644,877 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
54
Shares
1,394,012
Rows available
54
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
292
Q3 2026 holders
54
Holder diff
-238
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .